Palatal Wound
Conditions
Keywords
Connective tissue graft, Gingival recession, Low level laser therapy
Brief summary
The aim of this study was to compare two intensities of LLLT on wound healing process of the donor palatine area after CTG removal.
Detailed description
This is a prospective, parallel and controlled clinical trial. The population evaluated in the study was selected at Science and Technology Institute - ICT- São José dos Campos, College of Dentistry. Patients were assigned to one of the three treatment groups: * Group 60 (Test, n=18): Periodontal surgery for root coverage through connective tissue graft and LLLT application on donor site using a 60 J/cm² dose. * Group 30 (Test, n=18): Periodontal surgery for root coverage through connective tissue graft and LLLT application on donor site using a 30 J/cm² dose. * Group Sham (Control, n= 18): Periodontal surgery for root coverage through connective tissue graft and LLLT SHAM on donor site. All surgeries were performed by the same expert periodontist (MPS). Before the surgical procedure, all patients were enlightened about the causes and consequences of gingival recession and prevention techniques. Factors related to the origin of gingival recession, such as toothbrush trauma and inflammation caused by biofilm, were controlled through instruction on standardized brushing technique to avoid the influence of other hygiene methods capable of promoting trauma on soft tissues. Standardized dental floss and toothbrushes were given to patients. The surgical technique adopted in the recession defects was the trapezoidal-type of CAF and the connective tissue graft was removed from palate mucosa . Briefly, a first incision on the palate was performed perpendicularly to the long axis of the teeth, 2 to 3 mm apical to the gingival margin. The mesial-distal length of the incision was determined by the length of the graft required to cover the recession. Because the selected recessions were in maxillary canines and premolars, the lengths of the graft varied minimally (10-12mm). The second incision was made parallel to the first one (1-2 mm apically and parallel to the long axis of the teeth) to separate the subepithelium connective tissue from the epithelial layer. The incision is carried far enough apically to provide a 7- mm height of connective tissue to cover the denuded root surface. Afterward, another incision parallel to the long axis of the teeth starting from the first incision was performed to separate the subepithelium connective tissue from the periosteum. Then, the connective tissue graft was removed from the palate as atraumatically as possible. Single sutures were made on the palate (4-0 silk) and the graft was sutured on the receptor site. The evaluated parameters were wound remaining area (WRA), scar and tissue colorimetry (TC), tissue thickness (TT) and postoperative discomfort (D), evaluated at baseline and 7, 14, 45, 60, and 90 days after surgery. Statistical Analysis: All data were expressed as mean ± standard deviation or expressed in percentages during the descriptive phase. Data were analyzed according to distribution by the Shapiro-Wilk test. For the remaining wound area, tissue colorimetry, tissue thickness, and postoperative discomfort parameter analysis, two way repeated measures ANOVA was performed for intra- and intergroup analysis. T test was used for intergroup comparison of the number of analgesics taken. The presence or absence of scars was measured by Q-square test. Statistical analysis was performed using Sigma Plot 12.0. In all tests a significance level of 0.05 was chosen.
Interventions
Low Level Laser Therapy on the palatal donor site of connective tissue graft.
Utilization of GaAlAs laser to irradiation on the palatal donor site.
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients were 20 to 70 years old and of both genders, presenting Class I or II Miller gingival recession on vital canines or premolars in the palatine region (donor site) with no pathological or morphological alterations. * Patients agreed to and signed the formal consent to participate in the study after receiving an explanation of risks and benefits from an individual who was not a member of the present study (Resolution no. 196 - October, 1996, and Ethics and Code of Professional Conduct in Dentistry - CFO 179/93).
Exclusion criteria
* Were excluded patients with systemic problems that contraindicated surgical procedure * Those under medication that could interfere with the wound healing * Those who smoked * Those who were pregnant or lactating, and * Those who had had periodontal surgery on the study area.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in the Remaining Wound Area (RWA) | 7,14, 45 and 60 post operative days | For this, standardized photographs were taken (brightness, distance and angle). A scale was used as a reference to measure this area. These photographs were exported to image software ( Image J - NIH, Bethesda, USA) and remaining wound area was measured in square millimeters (mm²). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative Discomfort | 7, 14, 45, and 60 days after surgical procedure | After air jet application, patients were requested to score postoperative discomfort through on a visual analogue scale (VAS) of 10 centimeters, in which 0 meant no pain and 10 meant extreme pain. After this, a postoperative discomfort average for all groups was obtained. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Tissue Thickness | Before the procedure and 3 months after the procedure | Through four fixed points marked 5 and 7 mm from the gingival margin in the operated region, tissue thickness of palatine masticatory mucosa. One stent was made to standardize the points to be measured. The stent was positioned, and with a periodontal probe and the points were marked. Then the stent was removed and measurements were taken. For this, an endodontic spacer with a rubber cursor was put on the marked points for it to reach the palatine bone plate. Then the cursor was taken to the tissue carefully to not pressuring it. The distance between the spacer tip and the cursor was measured using a digital pachymeter and measured in millimeters (mm). |
Participant flow
Recruitment details
At clinical site
Participants by arm
| Arm | Count |
|---|---|
| Low Level Laser Therapy (LLLT) Sham The patients allocated to the control group received sham irradiation. For this, black rubber protection was placed at the tip of the laser device, which did not allow the light to reach the tissue. The applications were performed by a different operator (CAS) from the one who measured the study parameters. During irradiation, the tip of the laser probe was placed perpendicularly with slight contact on the area. Laser therapy was initiated in the immediate postoperative period (just after sutures) and was repeated by six more applications performed every other day, with a total of 7 laser applications.
Low Level Laser Therapy: Low Level Laser Therapy on the palatal donor site of connective tissue graft.
GaAlAs laser: Utilization of GaAlAs laser to irradiation on the palatal donor site. | 15 |
| GaAlAs Laser Therapy (LLLT) 60 J/cm² The irradiation was performed with a GaAlAs diode laser that continuously emitted a wavelength of 660 nm with a power of 30 mW. The patients allocated for the group 60 received the following protocol for laser application: Two (2) points of irradiation were performed using a total energy density (fluence) of 60 J/cm2 and a time of 60 seconds (30 J/cm2 per point and an application time of 30 seconds per point). During irradiation, the tip of the laser probe was placed perpendicularly with slight contact on the area. Laser therapy was initiated in the immediate postoperative period (just after sutures) and was repeated by six more applications performed every other day, with a total of 7 laser applications. The power of the equipment was calibrated prior to each application.
Low Level Laser Therapy: Low Level Laser Therapy on the palatal donor site of connective tissue graft.
GaAlAs laser: Utilization of GaAlAs laser to irradiation on the palatal donor site. | 18 |
| GaAlAs Laser Therapy (LLLT) 30 J/cm² The irradiation was performed with a GaAlAs diode laser that continuously emitted a wavelength of 660 nm with a power of 30 mW. The patients allocated for the group 30 received the following protocol for laser application: Two (2) points of irradiation were performed using a total energy density (fluence) of 30 J/cm2 and a time of 30 seconds (15 J/cm2 per point and an application time of 15 seconds per point). During irradiation, the tip of the laser probe was placed perpendicularly with slight contact on the area. Laser therapy was initiated in the immediate postoperative period (just after sutures) and was repeated by six more applications performed every other day, with a total of 7 laser applications. The power of the equipment was calibrated prior to each application.
Low Level Laser Therapy: Low Level Laser Therapy on the palatal donor site of connective tissue graft.
GaAlAs laser: Utilization of GaAlAs laser to irradiation on the palatal donor site. | 18 |
| Total | 51 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 | FG002 |
|---|---|---|---|---|
| Overall Study | Lost to Follow-up | 2 | 0 | 0 |
| Overall Study | Protocol Violation | 1 | 0 | 0 |
Baseline characteristics
| Characteristic | GaAlAs Laser Therapy (LLLT) 30 J/cm² | Total | Low Level Laser Therapy (LLLT) Sham | GaAlAs Laser Therapy (LLLT) 60 J/cm² |
|---|---|---|---|---|
| Age, Categorical <=18 years | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical >=65 years | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical Between 18 and 65 years | 18 Participants | 51 Participants | 15 Participants | 18 Participants |
| Age, Continuous | 47 years STANDARD_DEVIATION 9.3 | 43.4 years STANDARD_DEVIATION 8.9 | 40.01 years STANDARD_DEVIATION 7.6 | 43.2 years STANDARD_DEVIATION 9.8 |
| Region of Enrollment Brazil | 18 participants | 51 participants | 15 participants | 18 participants |
| Remaining wound area (RWA-mm2 ) | 65.74 square millimeters STANDARD_DEVIATION 25.08 | 59.6 square millimeters STANDARD_DEVIATION 22.28 | 62.91 square millimeters STANDARD_DEVIATION 23.27 | 50.15 square millimeters STANDARD_DEVIATION 18.49 |
| Sex: Female, Male Female | 11 Participants | 32 Participants | 8 Participants | 13 Participants |
| Sex: Female, Male Male | 7 Participants | 19 Participants | 7 Participants | 5 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk | EG002 affected / at risk |
|---|---|---|---|
| deaths Total, all-cause mortality | — / — | — / — | — / — |
| other Total, other adverse events | 0 / 15 | 0 / 18 | 0 / 18 |
| serious Total, serious adverse events | 0 / 15 | 0 / 18 | 0 / 18 |
Outcome results
Change in the Remaining Wound Area (RWA)
For this, standardized photographs were taken (brightness, distance and angle). A scale was used as a reference to measure this area. These photographs were exported to image software ( Image J - NIH, Bethesda, USA) and remaining wound area was measured in square millimeters (mm²).
Time frame: 7,14, 45 and 60 post operative days
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Low Level Laser Therapy (LLLT) Sham | Change in the Remaining Wound Area (RWA) | RWA 14 days | 29.86 Square millimeters | Standard Deviation 21.84 |
| Low Level Laser Therapy (LLLT) Sham | Change in the Remaining Wound Area (RWA) | RWA 7 days | 62.91 Square millimeters | Standard Deviation 23.27 |
| Low Level Laser Therapy (LLLT) Sham | Change in the Remaining Wound Area (RWA) | RWA 45 days | 6.63 Square millimeters | Standard Deviation 11.85 |
| Low Level Laser Therapy (LLLT) Sham | Change in the Remaining Wound Area (RWA) | RWA 60 days | 5.52 Square millimeters | Standard Deviation 9.37 |
| GaAlAs Laser Therapy (LLLT) 60 J/cm² | Change in the Remaining Wound Area (RWA) | RWA 60 days | 2.33 Square millimeters | Standard Deviation 2.95 |
| GaAlAs Laser Therapy (LLLT) 60 J/cm² | Change in the Remaining Wound Area (RWA) | RWA 7 days | 50.15 Square millimeters | Standard Deviation 18.49 |
| GaAlAs Laser Therapy (LLLT) 60 J/cm² | Change in the Remaining Wound Area (RWA) | RWA 14 days | 28.38 Square millimeters | Standard Deviation 13.89 |
| GaAlAs Laser Therapy (LLLT) 60 J/cm² | Change in the Remaining Wound Area (RWA) | RWA 45 days | 8.17 Square millimeters | Standard Deviation 6.66 |
| GaAlAs Laser Therapy (LLLT) 30 J/cm² | Change in the Remaining Wound Area (RWA) | RWA 60 days | 3.08 Square millimeters | Standard Deviation 2.96 |
| GaAlAs Laser Therapy (LLLT) 30 J/cm² | Change in the Remaining Wound Area (RWA) | RWA 45 days | 7.45 Square millimeters | Standard Deviation 7.93 |
| GaAlAs Laser Therapy (LLLT) 30 J/cm² | Change in the Remaining Wound Area (RWA) | RWA 7 days | 65.74 Square millimeters | Standard Deviation 25.08 |
| GaAlAs Laser Therapy (LLLT) 30 J/cm² | Change in the Remaining Wound Area (RWA) | RWA 14 days | 27.67 Square millimeters | Standard Deviation 16.16 |
Postoperative Discomfort
After air jet application, patients were requested to score postoperative discomfort through on a visual analogue scale (VAS) of 10 centimeters, in which 0 meant no pain and 10 meant extreme pain. After this, a postoperative discomfort average for all groups was obtained.
Time frame: 7, 14, 45, and 60 days after surgical procedure
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Low Level Laser Therapy (LLLT) Sham | Postoperative Discomfort | Pain 45 days | 0 units on a scale | Standard Deviation 0 |
| Low Level Laser Therapy (LLLT) Sham | Postoperative Discomfort | Pain 60 days | 0 units on a scale | Standard Deviation 0 |
| Low Level Laser Therapy (LLLT) Sham | Postoperative Discomfort | Pain 7 days | 0 units on a scale | Standard Deviation 0 |
| Low Level Laser Therapy (LLLT) Sham | Postoperative Discomfort | Pain 14 days | 0 units on a scale | Standard Deviation 0 |
| GaAlAs Laser Therapy (LLLT) 60 J/cm² | Postoperative Discomfort | Pain 7 days | 0 units on a scale | Standard Deviation 0 |
| GaAlAs Laser Therapy (LLLT) 60 J/cm² | Postoperative Discomfort | Pain 14 days | 0 units on a scale | Standard Deviation 0 |
| GaAlAs Laser Therapy (LLLT) 60 J/cm² | Postoperative Discomfort | Pain 60 days | 0.056 units on a scale | Standard Deviation 0.23 |
| GaAlAs Laser Therapy (LLLT) 60 J/cm² | Postoperative Discomfort | Pain 45 days | 0 units on a scale | Standard Deviation 0 |
| GaAlAs Laser Therapy (LLLT) 30 J/cm² | Postoperative Discomfort | Pain 60 days | 0 units on a scale | Standard Deviation 0 |
| GaAlAs Laser Therapy (LLLT) 30 J/cm² | Postoperative Discomfort | Pain 7 days | 0 units on a scale | Standard Deviation 0 |
| GaAlAs Laser Therapy (LLLT) 30 J/cm² | Postoperative Discomfort | Pain 14 days | 0 units on a scale | Standard Deviation 0 |
| GaAlAs Laser Therapy (LLLT) 30 J/cm² | Postoperative Discomfort | Pain 45 days | 0 units on a scale | Standard Deviation 0 |
Tissue Thickness
Through four fixed points marked 5 and 7 mm from the gingival margin in the operated region, tissue thickness of palatine masticatory mucosa. One stent was made to standardize the points to be measured. The stent was positioned, and with a periodontal probe and the points were marked. Then the stent was removed and measurements were taken. For this, an endodontic spacer with a rubber cursor was put on the marked points for it to reach the palatine bone plate. Then the cursor was taken to the tissue carefully to not pressuring it. The distance between the spacer tip and the cursor was measured using a digital pachymeter and measured in millimeters (mm).
Time frame: Before the procedure and 3 months after the procedure